Viral vectors are poised to acquire a prominent position in modern medicine and biotechnology owing to their role as delivery agents for gene therapies, oncolytic agents …
Z Yang, BCMF Paes, JPC Fulber, MY Tran, O Farnós… - Vaccines, 2023 - mdpi.com
The administration of viral vectored vaccines remains one of the most effective ways to respond to the ongoing novel coronavirus disease 2019 (COVID-19) pandemic. However …
The production of high-quality purified virus particles in high quantities for vaccine preparation requires a scalable purification procedure in the downstream step. A purification …
RP Fernandes, S Göbel, M Reiter, A Bryan… - Separation and …, 2025 - Elsevier
Oncolytic viruses (OV) have emerged as a promising approach to mitigate the challenges of treating solid cancers. However, the lack of established manufacturing and downstream …
W Shi, SN Zhu, H Xu, KB Li, SQ Zhang… - Industrial & …, 2023 - ACS Publications
This study investigated the potential of dual-ligand hydrophobic charge-induction chromatography for the simultaneous recovery of two high-value components (bovine serum …
S Neog, S Kumar, V Trivedi - Biomedical Chromatography, 2023 - Wiley Online Library
Newcastle disease virus (NDV), belonging to the species avian orthoavulavirus 1, genus Orthoavulavirus, and family Paramyxoviridae, is responsible for Newcastle disease in …
T Rogerson, G Xi, A Ampey, J Borman… - …, 2023 - Wiley Online Library
The use of viral vectors for vaccine, gene therapy, and oncolytic virotherapy applications has received increased attention in recent years. Large‐scale purification of viral vector‐based …
Background: Large-scale vaccine production requires downstream processing that focuses on robustness, efficiency, and cost-effectiveness. Methods: To assess the robustness of the …
Vaccine production is growing significantly every day. Immunization has regained its critical importance, particularly after the occurrence of the SARS-CoV-2 pandemic. When the entire …